Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Bioinformatics Grants Awarded Dec. 7, 2012 — Jan. 11, 2013

Premium

Project Title: Flexible Statistical Methods for Biomedical Data
Principal Investigator: Davidian, Marie
Organization: North Carolina State University, Raleigh
Project Start Date: May 1, 2000
Project End Date: Dec. 31, 2015
Funding Institute: NCI
FY Total Cost: $109,218


Project Title: FlyBase: A Drosophila Genomic and Genetic Database
Principal Investigator: Gelbart, William Martin
Organization: Harvard University
Project Start Date: Aug. 1, 1992
Project End Date: Dec. 31, 2013
Funding Institute: NHGRI
FY Total Cost: $3,407,816


Project Title: Design and Analysis of Human Gene Mapping Studies
Principal Investigator: Boehnke, Michael Lee
Organization: University of Michigan, Ann Arbor
Project Start Date: Sept. 28, 1988
Project End Date: Dec. 31, 2015
Funding Institute: NHGRI
FY Total Cost: $369,194


Project Title: Computer Methods for Physiological Problems
Principal Investigator: Hines, Michael L.
Organization: Yale University
Project Start Date: July 1, 1978
Project End Date: Dec. 31, 2017
Funding Institute: NINDS
FY Total Cost: $327,305


Project Title: Bayesian Spatial Point Process Modeling of Neuroimage Data
Principal Investigator: Johnson, Timothy D.
Organization: University of Michigan, Ann Arbor
Project Start Date: Apr. 1, 2012
Project End Date: Dec. 31, 2016
Funding Institute: NINDS
FY Total Cost: $267,002


Project Title: Statistical Methods for Analysis of High-Dimensional Gene and Environment Data
Principal Investigator: Maity, Arnab
Organization: North Carolina State University, Raleigh
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2013
Funding Institute: NIEHS
FY Total Cost: $277,548


Project Title: Robust Software Tools for Variant Identification and Functional Assessment
Principal Investigator: Marth, Gabor T.
Organization: Boston College
Project Start Date: Feb. 1, 2012
Project End Date: Dec. 31, 2015
Funding Institute: NHGRI
FY Total Cost: $872,545


Project Title: Supporting Integrative Genomic Analysis Users with GenePattern
Principal Investigator: Mesirov, Jill P.
Organization: Broad Institute
Project Start Date: June 1, 2005
Project End Date: Dec. 31, 2014
Funding Institute: NIGMS
FY Total Cost: $523,479


Project Title: Protégé: An Ontology Development Platform for Biomedical Scientists
Principal Investigator: Musen, Mark A.
Organization: Stanford University
Project Start Date: Jan 1, 2013
Project End Date: Dec. 31, 2016
Funding Institute: NIGMS
FY Total Cost: $533,554


Project Title: Haplotype-based Analysis Methods for Population Genomics
Principal Investigator: Novembre, John
Organization: University of California, Los Angeles
Project Start Date: Jan. 1, 2013
Project End Date: Dec. 31, 2017
Funding Institute: NHGRI
FY Total Cost: $292,233


Project Title: Design and Validation of a Biomarker-Enhanced System to Predict RCC Progression
Principal Investigator: Parker, Alexander S.
Organization: Mayo Clinic
Project Start Date: July 1, 2010
Project End Date: Dec. 31, 2014
Funding Institute: NCI
FY Total Cost: $190,459


Project Title: Predictive Experiment-based Multiscale Models of Angiogenesis in Breast Cancer
Principal Investigator: Popel, Aleksander S.
Organization: Johns Hopkins University
Project Start Date: Feb 13, 2009
Project End Date: Dec. 31, 2013
Funding Institute: NCI
FY Total Cost: $284,257


Project Title: Computational and Functional Approaches to Validating Cancer Genome Targets
Principal Investigator: Powers, Scott
Organization: Cold Spring Harbor Laboratory
Project Start Date: May 1, 2012
Project End Date: Apr. 30, 2017
Funding Institute: NHGRI
FY Total Cost: $250,000


Project Title: Computational Approaches for Structural Variation Studies in Genomes
Principal Investigator: Raphael, Benjamin
Organization: Brown University
Project Start Date: Jan. 1, 2011
Project End Date: Nov. 30, 2015
Funding Institute: NHGRI
FY Total Cost: $441,407


Project Title: Gene Expression Database for Mouse Development
Principal Investigator: Ringwald, Martin
Organization: Jackson Laboratory
Project Start Date: Dec. 2, 2010
Project End Date: Nov. 30, 2015
Funding Institute: NICHD
FY Total Cost: $2,078,119


Project Title: A Model Integrated Data Management System for Multidisciplinary Autism Research
Principal Investigator: Rozenblit, Leon
Organization: Prometheus Research
Project Start Date: Dec. 13, 2012
Project End Date: Nov. 30, 2014
Funding Institute: NIMH
FY Total Cost: $346,748


Project Title: Exact Statistical Tools for Genetic Association Studies
Principal Investigator: Senchaudhuri, Pralay
Organization: Cytel
Project Start Date: June 1, 2010
Project End Date: Dec. 31, 2014
Funding Institute: NHGRI
FY Total Cost: $480,325


Project Title: Computational Methods for Human Genomic Data Integration: Demography, Selection
Principal Investigator: Siepel, Adam Charles
Organization: Cornell University
Project Start Date: Jan. 1, 2013
Project End Date: Dec. 31, 2017
Funding Institute: NIGMS
FY Total Cost: $348,647


Project Title: A Publicly Accessible Cryptococcus Genome Database
Principal Investigator: Stajich, Jason Eric
Organization: University of California, Riverside
Project Start Date: Jan. 1, 2013
Project End Date: Dec. 31, 2014
Funding Institute: NIAID
FY Total Cost: $90,910


Project Title: Baylor-Johns Hopkins Center for Mendelian Genetics
Principal Investigator: Valle, David
Organization: Johns Hopkins University
Project Start Date: Dec. 5, 2011
Project End Date: Nov. 30, 2015
Funding Institutes: NHGRI, NHLBI
FY Total Cost: $3,573,189


Project Title: Image Analysis for High-throughput C. elegans Infection and Metabolism Assays
Principal Investigator: Wahlby, Carolina
Organization: Broad Institute
Project Start Date: Jan. 1, 2011
Project End Date: Dec. 31, 2015
Funding Institute: NIGMS
FY Total Cost: $280,773


Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.